FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2964007752> ?p ?o ?g. }

• W2964007752 endingPage "1007" @default.
• W2964007752 startingPage "999" @default.
• W2964007752 abstract "Inhibition of the anti-apoptotic machinery of cancer cells is a promising therapeutic approach that has driven the development of an important class of compounds termed “BH3 mimetics”. These novel small molecules mimic BH3-only proteins by antagonizing the pro-survival function of anti-apoptotic proteins, thereby inducing apoptosis in cancer cells. To qualify as an authentic BH3 mimetic, a compound must function directly on the mitochondria of a cell of known anti-apoptotic dependence, must directly and selectively inhibit the anti-apoptotic protein with high-affinity binding, and must induce mitochondrial outer membrane permeabilization (MOMP) and apoptosis in a BAX/BAK-dependent manner. While many BH3 mimetics have entered clinical trials, the lack of a reliable validation assay to directly test the mitochondrial activity of new BH3 mimetic candidates has resulted in many misleading reports of agents touted as BH3 mimetics despite their off-target mechanisms of action. BH3 profiling probes the activity of a compound at the mitochondrial level by measuring cytochrome c release as a surrogate marker for MOMP. We propose a comprehensive biochemical toolkit consisting of BH3 profiling in parallel with high-throughput Annexin V/Hoechst viability testing to validate BH3 mimetic candidates. We tested our toolkit on eighteen different putative BH3 mimetics using a set of standardized cell lines of known anti-apoptotic dependence. Included in this set of cell lines is an apoptosis refractory BAX/BAK DKO control line to detect compounds that function independently of the BCL-2 family. Taken together, this rapid, efficient means of testing will prove advantageous as the demand for BH3 mimetics increases, particularly in the quest to identify and develop more potent MCL-1 inhibitors for use in the clinic. We strongly urge researchers utilizing BH3 mimetics in their work to use the potent and selective compounds identified with this validation toolkit instead of those lacking such potency and selectivity." @default.
• W2964007752 created "2019-07-30" @default.
• W2964007752 creator A5022857112 @default.
• W2964007752 creator A5036561161 @default.
• W2964007752 creator A5055160574 @default.
• W2964007752 creator A5057707744 @default.
• W2964007752 creator A5073650549 @default.
• W2964007752 date "2019-07-22" @default.
• W2964007752 modified "2023-10-08" @default.
• W2964007752 title "BH3 profiling discriminates on-target small molecule BH3 mimetics from putative mimetics" @default.
• W2964007752 cites W1535142282 @default.
• W2964007752 cites W1834626755 @default.
• W2964007752 cites W1950569589 @default.
• W2964007752 cites W1972763059 @default.
• W2964007752 cites W1976998565 @default.
• W2964007752 cites W1986688227 @default.
• W2964007752 cites W1991213319 @default.
• W2964007752 cites W1999125751 @default.
• W2964007752 cites W2006366803 @default.
• W2964007752 cites W2016677282 @default.
• W2964007752 cites W2018104469 @default.
• W2964007752 cites W2034269086 @default.
• W2964007752 cites W2042811087 @default.
• W2964007752 cites W2059416155 @default.
• W2964007752 cites W2073239885 @default.
• W2964007752 cites W2083113305 @default.
• W2964007752 cites W2085419794 @default.
• W2964007752 cites W2088845956 @default.
• W2964007752 cites W2097007474 @default.
• W2964007752 cites W2109351911 @default.
• W2964007752 cites W2110525250 @default.
• W2964007752 cites W2123621979 @default.
• W2964007752 cites W2125499510 @default.
• W2964007752 cites W2161373285 @default.
• W2964007752 cites W2168632005 @default.
• W2964007752 cites W2172242534 @default.
• W2964007752 cites W2280585894 @default.
• W2964007752 cites W2294987656 @default.
• W2964007752 cites W2299192829 @default.
• W2964007752 cites W2313238950 @default.
• W2964007752 cites W2511071867 @default.
• W2964007752 cites W2534349779 @default.
• W2964007752 cites W2621963150 @default.
• W2964007752 cites W2885299475 @default.
• W2964007752 cites W2892573863 @default.
• W2964007752 cites W2905070646 @default.
• W2964007752 cites W2918143692 @default.
• W2964007752 doi "https://doi.org/10.1038/s41418-019-0391-9" @default.
• W2964007752 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7205860" @default.
• W2964007752 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31332296" @default.
• W2964007752 hasPublicationYear "2019" @default.
• W2964007752 type Work @default.
• W2964007752 sameAs 2964007752 @default.
• W2964007752 citedByCount "52" @default.
• W2964007752 countsByYear W29640077522019 @default.
• W2964007752 countsByYear W29640077522020 @default.
• W2964007752 countsByYear W29640077522021 @default.
• W2964007752 countsByYear W29640077522022 @default.
• W2964007752 countsByYear W29640077522023 @default.
• W2964007752 crossrefType "journal-article" @default.
• W2964007752 hasAuthorship W2964007752A5022857112 @default.
• W2964007752 hasAuthorship W2964007752A5036561161 @default.
• W2964007752 hasAuthorship W2964007752A5055160574 @default.
• W2964007752 hasAuthorship W2964007752A5057707744 @default.
• W2964007752 hasAuthorship W2964007752A5073650549 @default.
• W2964007752 hasBestOaLocation W29640077521 @default.
• W2964007752 hasConcept C14036430 @default.
• W2964007752 hasConcept C161624437 @default.
• W2964007752 hasConcept C185592680 @default.
• W2964007752 hasConcept C190283241 @default.
• W2964007752 hasConcept C28859421 @default.
• W2964007752 hasConcept C29311851 @default.
• W2964007752 hasConcept C31573885 @default.
• W2964007752 hasConcept C54355233 @default.
• W2964007752 hasConcept C55493867 @default.
• W2964007752 hasConcept C70721500 @default.
• W2964007752 hasConcept C81885089 @default.
• W2964007752 hasConcept C86803240 @default.
• W2964007752 hasConcept C88634738 @default.
• W2964007752 hasConcept C95444343 @default.
• W2964007752 hasConceptScore W2964007752C14036430 @default.
• W2964007752 hasConceptScore W2964007752C161624437 @default.
• W2964007752 hasConceptScore W2964007752C185592680 @default.
• W2964007752 hasConceptScore W2964007752C190283241 @default.
• W2964007752 hasConceptScore W2964007752C28859421 @default.
• W2964007752 hasConceptScore W2964007752C29311851 @default.
• W2964007752 hasConceptScore W2964007752C31573885 @default.
• W2964007752 hasConceptScore W2964007752C54355233 @default.
• W2964007752 hasConceptScore W2964007752C55493867 @default.
• W2964007752 hasConceptScore W2964007752C70721500 @default.
• W2964007752 hasConceptScore W2964007752C81885089 @default.
• W2964007752 hasConceptScore W2964007752C86803240 @default.
• W2964007752 hasConceptScore W2964007752C88634738 @default.
• W2964007752 hasConceptScore W2964007752C95444343 @default.
• W2964007752 hasIssue "3" @default.
• W2964007752 hasLocation W29640077521 @default.
• W2964007752 hasLocation W29640077522 @default.
• W2964007752 hasOpenAccess W2964007752 @default.

• next